|D017563||Lung Diseases, Interstitial NIH||0.45|
There is one clinical trial.
Currently there are no proven treatment option for COVID-19. Human convalescent plasma is an option for COVID-19 treatment and could be available from people who have recovered and can donate plasma.
Description: reduction in oxygen and ventilation supportMeasure: reduction in oxygen and ventilation support Time: through study completion, an average of 4 weeks